Jamjoom Pharmaceuticals Factory Company

SASE:4015 Stock Report

Market Cap: ر.س10.8b

Jamjoom Pharmaceuticals Factory Balance Sheet Health

Financial Health criteria checks 6/6

Jamjoom Pharmaceuticals Factory has a total shareholder equity of SAR1.4B and total debt of SAR0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SAR1.9B and SAR412.8M respectively. Jamjoom Pharmaceuticals Factory's EBIT is SAR371.3M making its interest coverage ratio 3564.4. It has cash and short-term investments of SAR121.8M.

Key information

0%

Debt to equity ratio

ر.س0

Debt

Interest coverage ratio3564.4x
Cashر.س121.82m
Equityر.س1.44b
Total liabilitiesر.س412.83m
Total assetsر.س1.86b

Recent financial health updates

No updates

Recent updates

Getting In Cheap On Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) Is Unlikely

Apr 30
Getting In Cheap On Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) Is Unlikely

Financial Position Analysis

Short Term Liabilities: 4015's short term assets (SAR1.1B) exceed its short term liabilities (SAR334.9M).

Long Term Liabilities: 4015's short term assets (SAR1.1B) exceed its long term liabilities (SAR77.9M).


Debt to Equity History and Analysis

Debt Level: 4015 is debt free.

Reducing Debt: 4015 has no debt compared to 5 years ago when its debt to equity ratio was 3.7%.

Debt Coverage: 4015 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 4015 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies